Built for protocol owners

Nursing education, pharmacy library owners, patient safety, and biomedical engineering— soft pipeline only until clearance.

Regulatory status. TMEDS is not FDA cleared or approved. It is not for clinical use and is not for sale as a medical device. Contributions support research, engineering, and regulatory preparation. TMEDS does not eliminate professional or institutional liability.

Future commercial motion

After regulatory authorization, the intended offering is a capital dock, keyed inserts, and annual software/library support—aimed at enforcing ordered push timing and retaining an administration record.

Target list pricing (not available for purchase today): dock about $4,800, annual support about $1,200 per device, insert sets about $180. Figures are planning targets only.

What we will not do yet

We will not sell clinical units, place devices in patient care, or claim that TMEDS removes liability or produces clinical outcomes. Discovery calls are for champions who want to follow the regulatory journey.

Hospital interest list

Soft pipeline only. Joining does not order a device and does not enroll in a clinical study.